Polaryx Therapeutics, Inc. (PLYX) vs VAXART, INC. (VXRT)

Polaryx Therapeutics, Inc. and VAXART, INC. are both Biotechnology companies. Polaryx Therapeutics, Inc. and VAXART, INC. are of similar size ($92.4M and $89.7M). Polaryx Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. has the higher net margin (16.0% vs 0.00%) and the higher return on invested capital (2,542.3% vs 0.00%). Across the 12 metrics below, VAXART, INC. leads on 11 and Polaryx Therapeutics, Inc. on 1.

Valuation

Metric PLYX VXRT Biotechnology median
P/E n/m 2.85 10.26
P/S n/m 0.50 9.18
P/B 7.94 1.36 2.05
Price to free cash flow n/m 2.81 24.81
EV/EBITDA n/m 0.56 0.65
EV/Sales n/m 0.14 8.98
Earnings yield (12.03%) 35.14% (34.89%)
Free cash flow yield (9.48%) 35.55% (24.52%)

Profitability

Metric PLYX VXRT Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% 16.63% 0.00%
Net margin 0.00% 16.02% 0.00%
Free cash flow margin 0.00% 17.64% 0.00%
Return on equity 0.00% 62.42% (50.12%)
Return on assets (169.05%) 16.26% (45.60%)
Return on invested capital 0.00% 2,542.26% 0.00%

Growth

Metric PLYX VXRT Biotechnology median
Revenue growth (TTM) — 22.31% 6.26%
EPS growth (last fiscal year) 77.72% 121.21% 29.88%
Revenue growth, 5-year CAGR — 125.76% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric PLYX VXRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.53 1.71 4.89
Net debt to EBITDA 0.66 (2.42) 1.01

Dividend

Metric PLYX VXRT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PLYX VXRT Biotechnology median
Market cap 89.72m 92.41m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack